Health Sciences In The Media

University of Arizona’s College of Medicine in Phoenix had a double digit increase in the number of applications compared to last year and it could be influenced by the nation’s top infectious disease expert.

As the vaccines roll out, so do questions and concerns. Dr. Elizabeth Connick, chief of the Division of Infectious Diseases at the UArizona College of Medicine – Tucson, called the vaccine a home run. "These are some of the most important accomplishments in medicine in the last 25 years." Overall, Dr. Connick said, it’s the same vaccine but there are a few differences. "Preliminarily, it does seem like the Moderna causes more side effects, more fatigue and particularly after the second dose. But it could be because you're getting a great immune response."

Tens of thousands of health care workers in Maricopa County have signed up to receive the COVID-19 vaccine. Dr. Shad Marvasti, director of public health, prevention and health promotion with the University of Arizona College of Medicine – Phoenix, is interviewed.

Sandra Kurtin, PhD, ANP-C, AOCN, of the University of Arizona Cancer Center, discusses the challenges for advanced practitioners treating patients with hematologic malignancies who are at high risk for COVID-19 infection.

Dr. Anthony S. Fauci and several epidemiologists and health and science writers for The New York Times discuss their predictions about the months ahead. "I won't take traveling to my extended family for granted," said Alicia Allen, PhD, MPH, an assistant professor of clinical translational sciences at the University of Arizona College of Medicine – Tucson.

An encouraging new study at the University of Arizona could lead to new immunotherapy treatments for Type-1 diabetes and could be extended to other autoimmune diseases. The study involves genetically engineered T-cells that can seek out and destroy pathogens in the pancreas. The research was led by Michael Kuhns, an associate professor of immunobiology in the UArizona College of Medicine - Tucson.

The coronavirus has upended almost all aspects of life this year, and that includes the holiday giving and volunteering that credit unions traditionally do. Kelly Reynolds, a professor and environmental microbiologist at the University of Arizona Mel and Enid Zuckerman College of Public Health, is interviewed.

Dr. Sam Keim, a professor of emergency medicine at the University of Arizona College of Medicine - Tucson, is interviewed about his experiences as a clinical trial participant in Moderna's COVID-19 vaccine

A team at the University of Arizona Health Sciences found that SARS-CoV-2 antibodies provide lasting immunity. This finding suggested that those who had survived an infection and those who received a vaccine for COVID-19 would be immune from reinfection for several months.

Kelly A. Reynolds, PhD, MSPH, a professor and environmental microbiologist at the University of Arizona Mel and Enid Zuckerman College of Public Health, writes about the effectiveness of sanitary survey scores to predict water quality at the point of use.